3M technologies are being used around the world to manufacture life-saving medications, including COVID-19 vaccines and therapeutics.
Among those products is a 3M-developed vaccine adjuvant called 3M-052. An adjuvant is used to boost the immune response and enhance the efficacy of vaccines being developed to fight evolving strains of COVID-19 and future coronavirus outbreaks.
3M scientists Mark Tomai and George Griesgraber recently sat down with the American Chemical Society to talk about the adjuvant developed by their team.
3M-052 was used in a recent Duke study that showed great promise in the fight against coronavirus variants. The results were published recently in Nature.
You can learn more about adjuvants – what they are and how they help vaccines work better – at 3M Health Care.